Department of Medicine, University of New Mexico School of Medicine and Medicine Service, Medicine Service, New Mexico Health Care System, Albuquerque, New Mexico.
Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Am J Prev Med. 2014 Sep;47(3):251-9. doi: 10.1016/j.amepre.2014.04.011. Epub 2014 Jun 9.
Clinicians are encouraged to support patients in achieving shared decision making (SDM) for cancer screening.
To describe decision making processes and outcomes for cancer screening discussions.
A 2011 national Internet survey of adults aged ≥50 years who made cancer screening decisions (breast, BrCa; colorectal, CRC; prostate, PCa) within the previous 2 years was conducted. Participants were asked about their perceived cancer risk; how informed they felt about cancer tests; whether their healthcare provider addressed pros/cons of testing, presented the option of no testing, and elicited their input; whether they were tested; and their confidence in the screening decision. Data were analyzed in 2013-2014 with descriptive statistics and logistic regression.
Overall, 1,134 participants (477 men, 657 women) aged ≥50 years made cancer screening decisions, and 1,098 (354, BrCa; 598, CRC; 146, PCa) decisions were discussed with a healthcare provider. Most discussions (51%-67%) addressed pros of screening some or a lot, but few (7%-14%) similarly addressed cons. For all cancer screening decisions, providers usually (63%-71%) explained that testing was optional, but less often asked women (43%-57%) than men (70%-71%) whether they wanted testing. Only 27%-38% of participants reported SDM, 69%-93% underwent screening, and 55%-76% would definitely make the same decision again. Perceived high/average cancer risk and feeling highly informed were associated with confidence in the screening decision.
Discussions often failed to provide balanced information and meet SDM criteria. Supporting SDM could potentially improve the quality of cancer screening decisions.
鼓励临床医生支持患者参与癌症筛查的共同决策(SDM)。
描述癌症筛查讨论的决策过程和结果。
对 2011 年进行的一项全国性互联网调查进行了描述,该调查对象为过去 2 年内进行过癌症筛查决策(乳腺癌,BrCa;结直肠癌,CRC;前列腺癌,PCa)的≥50 岁成年人。参与者被问及他们对癌症风险的感知;他们对癌症检测的了解程度;他们的医疗保健提供者是否讨论了检测的利弊、提出了不检测的选择并征求了他们的意见;他们是否接受了检测;以及他们对筛查决策的信心。数据分析于 2013-2014 年进行,采用描述性统计和逻辑回归。
共有 1134 名(477 名男性,657 名女性)≥50 岁的参与者做出了癌症筛查决策,其中 1098 名(354 名,BrCa;598 名,CRC;146 名,PCa)的决策是与医疗保健提供者讨论的。大多数讨论(51%-67%)涉及筛查一些或很多方面的利弊,但很少(7%-14%)同样涉及缺点。对于所有癌症筛查决策,提供者通常(63%-71%)解释测试是可选的,但询问女性(43%-57%)的情况比询问男性(70%-71%)少。只有 27%-38%的参与者报告了 SDM,69%-93%接受了筛查,55%-76%肯定会再次做出相同的决定。感知到的高/中等癌症风险和高度知情与对筛查决策的信心相关。
讨论往往未能提供平衡的信息并满足 SDM 的标准。支持 SDM 可能会提高癌症筛查决策的质量。